Skip to main content

Table 1 Clinical and physiological variables in patients with bronchial asthma and control subjects

From: Serum angiopoietin is associated with lung function in patients with asthma: a retrospective cohort study

 

Normal controls

Asthmatic patients

Variables

n = 20

n = 35

Age, yr

51.4 (±8.9)

46.6 (±13.7)

Sex (M/F)

13/7

15/20

Smoke (SM/ES/NS)

5/2/10

5/8/20

Atopy (Y/N)

6/14

17/18

Asthma period, yr

0

1.53 (±0.72)

IgE (pg/ml)

72.08 (±84.0)

260.11 (±514.0)

BMI (kg/m2)

23.72 (±2.89)

23.97 (±3.01)

FVC (%, predicted)

91.40 (±9.1)

73.00 (±14.6)*

FEV1 (%, predicted)

103.0 (±8.7)

74.0 (±16.6)*

FEV1/FVC %

86.0 (±4.9)

74.9 (±10.8)*

PC20 methacholine

23.87 (±5.05)

3.11 (±4.63)*

  1. *p < 0.001 compared with control subjects.
  2. Plus-minus values are mean ± S.D. PC20 methacholine; the concentration of methacholine required to decrease the FEV1 by 20%, FEV1; forced expiratory volume in one second. FVC; forced vital capacity. BMI; body mass index. SM; smoker, ES; ex-smoker, NS; non-smoker.